Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of 1369.704 pence per Ordinary share on 9 July 2011 through the Company's Share Reward Plan ("the Plan").
Mr A P Witty |
Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S M Bicknell |
Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr E J Gray |
Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S A Hussain |
Acquisition of 7 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Dr D Pulman |
Acquisition of 11 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr D S Redfern |
Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Ms C Thomas |
Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr P C Thomson |
Acquisition of 12 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Dr P J T Vallance |
Acquisition of 14 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mrs V A Whyte |
Acquisition of 25 Ordinary shares under the Dividend Reinvestment element of the Plan
|
The Company and the above-mentioned persons were advised of this information on 11 July 2011.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
11 July 2011